Vaginal Bromocriptine for Treatment of Adenomyosis
Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
Adenomyosis is a rare non-malignant disease of the uterus that causes significant symptoms
including heavy menstrual bleeding and pelvic pain. The only widely accepted treatment for
adenomyosis is hysterectomy. The investigators will use a dopamine agonist, bromocriptine, as
a therapy based on animal models of the disease and our prior clinical research to observe
any objective improvement in the extent of the disease using Magnetic Resonance Imaging
(MRI)and standard measurements for other gynecologic diseases to measure symptomatology.